FDA recall D-0437-2024

Product

Rifampin Capsules USP, 300mg, 30-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited Aurangabad 431 210 India, NDC 6818-0659-06

Reason for recall

Subpotent Drug

Distribution

Nationwide within the United States

Key facts

Status

Terminated

Initiation date

2024-03-21

Report date

2024-04-17

Termination date

2025-04-04

Voluntary/Mandated

Voluntary: Firm initiated

Location

Baltimore, MD, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0437-2024